Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2026-06-02 @ 9:31 PM
Study NCT ID:
NCT03721757
Status:
COMPLETED
Last Update Posted:
2025-02-25
First Post:
2018-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
Sponsor:
The Clatterbridge Cancer Centre NHS Foundation Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
C0947
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None